Total planned funding: $45,815,864
Allocations
Countries/Regions
| Central Asia Region | $45,815,864 |
Organizational Types
| Own Agency | $12,984,186 |
| Unknown | $10,321,709 |
| NGO | $7,103,170 |
| University | $6,121,700 |
| Host Country Government Agency | $5,007,870 |
| Private Contractor | $3,632,129 |
| Multi-lateral Agency | $420,000 |
| Implementing Agency | $167,000 |
| Other USG Agency | $58,100 |
Program Areas
| Prevention | $15,816,681 |
| Management and Operations | $9,890,646 |
| Governance and Systems | $9,088,356 |
| Care | $4,952,050 |
| Treatment | $3,204,257 |
| Testing | $2,863,874 |
Budget Codes
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,742,636 |
| HVMS: Management and Operations | $9,890,646 |
| HBHC: Care: Adult Care and Support | $4,029,435 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $3,790,104 |
| OHSS: Health Systems Strengthening | $3,382,175 |
| HLAB: Laboratory Infrastructure | $3,300,036 |
| HTXS: Treatment: Adult Treatment | $3,171,088 |
| HVCT: Testing: HIV Testing and Counseling | $2,863,874 |
| HVSI: Strategic Information | $2,406,145 |
| HMBL: Biomedical Prevention: Blood Safety | $934,556 |
| HVTB: Care: TB/HIV | $922,615 |
| HMIN: Biomedical Prevention: Injection Safety | $349,385 |
| HTXD: Treatment: ARV Drugs | $33,169 |
Top Partner Programs
Not Available:
$10,321,709
Countries/Regions
Central Asia Region
| 2011 | $1,092,788 |
| 2012 | $1,913,199 |
| 2014 | $7,315,722 |
USG Aggregated Agencies:
$7,621,823
Countries/Regions
Central Asia Region
| 2011 | $5,099,999 |
| 2012 | $1,121,824 |
| 2017 | $1,400,000 |
Columbia University:
$6,121,700
Countries/Regions
Central Asia Region
| 2011 | $927,743 |
| 2012 | $979,042 |
| 2014 | $1,051,915 |
| 2017 | $3,163,000 |
Population Services International:
$5,312,378
Countries/Regions
Central Asia Region
| 2011 | $3,310,994 |
| 2012 | $0 |
| 2014 | $0 |
| 2017 | $2,001,384 |
Abt Associates:
$3,632,129
Countries/Regions
Central Asia Region
| 2011 | $2,232,129 |
| 2012 | $0 |
| 2014 | $1,400,000 |